Miraba 5

Presentation: Tablets containing Mirogabalin Besilate equivalent to Mirogabalin 5 mg.

Indications: Indicated for the treatment of neuropathic pain, including diabetic peripheral neuropathic pain (DPNP), postherpetic neuralgia (PHN), and peripheral neuropathic pain (PNP).

Dosage & Administration: Adults: The initial dose is 5 mg twice daily. The dose may be gradually increased by 5 mg at weekly intervals to a maximum of 15 mg twice daily, based on individual response and tolerability. May be taken with or without food. Dosage adjustment is required in patients with renal impairment.

Side Effects: Common side effects may include somnolence, dizziness, edema, and weight gain. Less common side effects may include lightheadedness, loss of consciousness, general malaise, loss of appetite, nausea, vomiting, and jaundice.

Precautions: Contraindicated in patients with hypersensitivity to mirogabalin. Exercise caution in patients with renal impairment; dosage adjustment is necessary. Avoid consuming alcohol while taking this medication as it may potentiate the impairment of motor skills and sedating effects. May cause dizziness, somnolence, or loss of consciousness; caution should be exercised while driving or operating machinery. May cause blurred or double vision.

Storage: Store below 30°C in a dry place, protected from light. Keep out of reach of children.

Note: Please consult your healthcare professional for personalized medical advice.